Immupharma Share Price (IMM)

11.73 0.00 (0.00%) delayed: 3:36PM BST
Bid price 11.10 Open price 11.83
Ask price 12.35 Prev close 11.73
High price 0.00 Spread 10.12%
Low price 0.00 Volume 0

Register now for FREE live Immupharma share prices, Immupharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Immupharma Level 2 Data, indepth research tools and investor commentary for Immupharma (IMM) and other London Stock Exchange equities.

Immupharma Share Price Chart

Advanced Charts >>

Register now for FREE Immupharma share price charts

Immupharma Share Price Information

Name ImmuPharma Epic IMM
Sector n/a ISIN GB0033711010
Activites n/a Index n/a

Immupharma Director Deals

Dec.Date Type Director Pos No. of Shares
07/09/2023 BUY Lisa Baderoon NED 1,000,000
11/08/2022 BUY Timothy McCarthy CH 1,200,000
11/08/2022 BUY Timothy Franklin ED 400,000
11/08/2022 BUY Lisa Baderoon NED 400,000
24/08/2021 BUY Timothy Franklin ED 125,000

More Immupharma Director Deals >>

Immupharma Company News

07:00 02/12/2020

IMM TO PRESENT AT BIOTECH SHOWCASE DIGITAL 2021

RNS Number : 1444H Immupharma PLC 02 December 2020       ImmuPharma PLC ("ImmuPharma" or the "Company")   IMMUPHARMA TO PRESENT AT BIOTECH...

07:00 30/11/2020

Total Share Capital Notification

RNS Number : 8128G Immupharma PLC 30 November 2020   RNS | eCorporate  30 November 2020   ImmuPharma PLC ("ImmuPharma" or the "Company")   Total...

07:00 26/11/2020

Grant of Share Options & PDMR dealing

RNS Number : 5422G Immupharma PLC 26 November 2020   RNS / eCorporate 26 November 2020   ImmuPharma PLC...

More Immupharma Company News >>

Register now for FREE Immupharma company news

Immupharma Share Price Discussions

more than 1 year ago

IMMUPHARMA - small bio, big potential (IMM)

From today's Times: Tiddler to watch "ImmuPharma, steady at 46p, the biotech group which has a treatment of the disease Lupus in phase II trials, could benefit from the failure this week of trials of rival drug Rituxan. ImmuPharma's housebroker, Panmure Gordon, believes its client may attract...

Register now for FREE Immupharma share price discussions